CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin

• Holly R. Keir,
• Hollian Richardson,
• Christina Fillmore,
• Amelia Shoemark,
• Aili L. Lazaar,
• Bruce E. Miller,
• Ruth Tal-Singer,
• James D. Chalmers,
• Divya Mohan

Affiliations

Holly R. Keir

Ninewells Clinical Research Centre, University of Dundee, Dundee, UK

Hollian Richardson

Ninewells Clinical Research Centre, University of Dundee, Dundee, UK

Christina Fillmore

GSK R&D, Stevenage, UK

Amelia Shoemark

Ninewells Clinical Research Centre, University of Dundee, Dundee, UK

Aili L. Lazaar

GSK R&D, Collegeville, PA, USA

Bruce E. Miller

GSK R&D, Collegeville, PA, USA

Ruth Tal-Singer

GSK R&D, Collegeville, PA, USA

James D. Chalmers

Ninewells Clinical Research Centre, University of Dundee, Dundee, UK

Divya Mohan

GSK R&D, Collegeville, PA, USA